PDCD1 and colorectal cancer: This study evaluated the effect of the probiotic, L. rhamnosus Probio-M9, on anti-PD-1-based ICB treatment using a heterotopic in vivo model of colorectal cancer constructed in mice with antibiotic-disrupted gut microbiota.